Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1
{{output}}
Janus kinases (JAKs) are a family of four enzymes; JAK1, JAK2, JAK3 and tyrosine kinase 2 (TYK2) that are critical in cytokine signalling and are strongly linked to both cancer and inflammatory diseases. There are currently two launched JAK inhibitors for the ... ...
